The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
Ovarian cancer is one of the most common gynecological malignancies with highest mortality rate among all gynecological malignant tumors. Advanced ovarian cancer patients can obtain a survival benefit from chemotherapy, including platinum drugs and paclitaxel. In more recent years, the administratio...
Main Authors: | Hua Lan, Jing Yuan, Da Zeng, Chu Liu, Xiaohui Guo, Jiahui Yong, Xiangyang Zeng, Songshu Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.693259/full |
Similar Items
-
The Role of Non-coding RNAs in Viral Myocarditis
by: Cong Zhang, et al.
Published: (2020-07-01) -
Circular RNAs in cancer: new insights into functions and implications in ovarian cancer
by: Zahra Shabaninejad, et al.
Published: (2019-09-01) -
Pathophysiology and Clinical Utility of Non-coding RNAs in Epilepsy
by: Yiye Shao, et al.
Published: (2017-08-01) -
The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
by: Jinning Gao, et al.
Published: (2017-03-01) -
The Role of Non-Coding RNAs in the Neuroprotective Effects of Glutathione
by: Chisato Kinoshita, et al.
Published: (2021-04-01)